Overview

Exercise and GLP-1 RA on Insulin Secretion

Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of endurance exercise on insulin secretory capacity, alone or in addition to treatment with the glucagon-like-peptide receptor agonist semaglutide, in patients with type 2 diabetes.
Phase:
N/A
Details
Lead Sponsor:
University of Copenhagen